Vanguard's Disclosure on Mural Oncology Holding

The Vanguard Group, Inc. has disclosed its position concerning Mural Oncology plc under the rules of the Irish Takeover Panel Act, 1997. As of September 3, 2025, Vanguard holds a 4.47% stake in Mural Oncology, equating to 771,363 ordinary shares. This disclosure follows regulations necessitating reporting from entities holding an interest of 1% or more in relevant securities.

Vanguard reported selling 48 ordinary shares at a price of $2.07 per share. No additional dealings, such as cash or stock-settled derivative transactions, were mentioned. Furthermore, Vanguard stated no indemnity, option arrangements, or other agreements associated with these securities.